DOSSIER · 13F Holders · Q3 2026
LINEAGE CELL THERAPEUTICS IN
3 institutions still hold LINEAGE CELL THERAPEUTICS IN as of Q3 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 53566P909·3 13F holders·last filed Sep 30, 2026
AI Holders Summary · Q3 2026
3 institutions reported LINEAGE CELL THERAPEUTICS IN in Q3 2026. SIMPLEX TRADING, LLC leads at 80.9% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.